The brest cancer predisposing genes BRCA1 and BRCA2 appear to be involved in DNA repair. In particular, the sensitivity of BRCA2-de®cient mouse embryonic ®broblasts to ionizing radiation and the demonstrated interaction of the BRCA2 protein with Rad51, a major factor in recombinational repair, indicate that BRCA2 is important for double strand break repair. The human BRCA2-de®cient human cell line Capan-1, whilst being sensitive to ionizing radiation, is also sensitive to the alkylating agent methymethanesulfonate. The major lesions induced by this agent are methylated bases which are removed primarily by the base excision repair (BER) pathway. We have investigated the eciency of BER in Capan-1 cells by an in vitro assay in which plasmid substrates containing a single lesion are repaired by mammalian cell extracts. In comparison to the control cell lines BxPC-3, T24 and MCF7, Capan-1 cells exhibited a reduced rate of DNA ligation during both the single-nucleotide insertion and PCNA-dependent pathways of BER. The reduced rate of DNA ligation exhibited by Capan-1 cell extracts was complemented by addition of bacteriophage T4 DNA ligase or human DNA ligase III. BRCA2-mutant Capan-1 cells may possess reduced DNA ligase activity during BER.
Introduction
About 10% of breast cancer patients have a familial form of the disease and inherited mutations of the breast cancer predisposing genes BRCA1 and BRCA2 are found in approximately half of these familial cases (reviewed in Rahman and Stratton, 1998) . The BRCA1 and BRCA2 genes encode two large nuclear proteins of 1863 and 3418 amino acids respectively, the sequences of which provide few clues as to their biological functions. A clearer understanding of the biochemical role of the BRCA proteins will increase our understanding of the origin of breast cancer and help determine whether gene therapy with BRCA genes may be a useful clinical approach. Homozygosity for targeted mutations in murine BRCA1 or BRCA2 results in defective cell division, chromosomal instability and hypersensitivity to genotoxins, indicative of defects in DNA repair (Ludwig et al., 1997; Patel et al., 1998) . In particular mouse embryonic ®broblasts (MEFs) carrying insertional mutations that delete the BRCA2 COOH terminus are hypersensitive to ionizing radiation (Connor et al., 1997; Sharan et al., 1997; Morimatsu et al., 1998; Patel et al., 1998) . These cells maintain the G 1 -S and G 2 -M checkpoints, suggesting that defective DNA repair may be the main cause of their radiosensitivity (Morimatsu et al., 1998) . In agreement with this, Connor et al., (1997) demonstrated defective DNA double-strand break repair in BRCA2 knockout MEFs. The BRCA2 protein participates with RAD51, with which it interacts, to facilitate the repair of DNA by homologous recombination (Sharan et al., 1997; Scully et al., 1997; Chen et al., 1998) . Defective DNA double-strand break repair has been demonstrated in the human BRCA2-mutant cell line Capan-1, which expresses a truncated form of the BRCA2 protein lacking the COOH terminus (Goggins et al., 1996 , Abbott et al., 1998 Chen et al., 1998) . In addition to ionizing radiation, Capan-1 cells are also sensitive to the alkylating agent methylmethanesulphonate [MMS (Chen et al., 1998) ], which induces DNA damage that is repaired primarily via base excision repair (BER). The loss of BRCA2 in human cells may thus lead to biochemical defects in more than one DNA repair pathway. Consistent with this notion, we report here that Capan-1 cells exhibit a reduced rate of DNA ligation during BER, in vitro.
Results

Capan-1 cell-free extracts exhibit a DNA ligation defect during BER
The human pancreatic adenocarcinoma cell line Capan-1 contains no functional BRCA2 protein as it lacks one copy of the BRCA2 gene and contains a mutation (the 6174delT commonly found in the Ashkenazi Jewish population (Neuhausen et al., 1996) in the remaining copy (Abbott et al., 1998) . This mutation truncates the carboxyl-terminal half of the BRCA2 protein, deleting the domain which has been shown to interact with Rad51 (Abbott et al., 1998) . Consequently, only a truncated form of the BRCA2 protein is present in Capan-1 cells (Chen et al., 1998) . In order to investigate the possible role of BRCA2 in BER, repair replication experiments were conducted utilizing Capan-1 cell extracts and DNA plasmid substrates that harbor a single AP site (pGEM X) or a single U (pGEM U) located centrally (7th bp) within an XbaI ± PstI 16-mer restriction fragment (Figure 1 ).
After incubation with the cell extracts and subsequent recovery from the BER reaction, the BER products were digested with XbaI and PstI and separated by denaturing polyacrylamide gel electrophoresis. Whereas the presence of radiolabeled 16-mer fragments re¯ects completed BER events, the presence of radiolabelled 7-15-mer fragments indicates the persistence of unligated intermediates of BER. Furthermore, whereas the persistence of radiolabelled 7 mers re¯ects unligated intermediates arising from the single nucleotide insertion pathway, the persistence of radiolabelled 8 ± 15 mers re¯ects unligated intermediates arising from multiple nucleotide insertion events. As previously shown, these occur via polymerase b (Dianov et al., 1992) or PCNA-dependent synthesis (Frosina et al., 1996) , respectively.
Cell extracts from three control cell lines were employed in this study to evaluate the eciency of BER conducted by Capan-1 cell extracts. Of the three control cell lines, all of which contain full-length BRCA2 protein, BxPC-3 is most like the BRCA2 mutant cell line Capan-1. It is a well-dierentiated pancreatic adenocarcinoma cell line that also shows a loss of heterozygosity at the BRCA2 locus (Livingston, 1997) but, unlike Capan-1, has one remaining normal BRCA2 allele (Abbott et al., 1998) . BxPC-3 cells also match Capan-1 cells in the mutation status of a number of tumor suppressor genes, since neither cell line contains functional p53, p16 or Rb (Redston et al., 1994; Livingston, 1997; Schutte et al., 1997) . Indeed, BxPC3 cells are employed in many studies as a control for Capan-1 cells (Abbott et al., 1998; Su et al., 1998; Yuan et al, 1999) . The T24 and MCF7 cell lines derive from a bladder and a breast carcinoma respectively and may also be used as control cells that express fulllength BRCA2 protein (Chen et al., 1998; Su et al., 1998) . The representative experiment in Figure 2 shows that the single AP site is repaired eciently by the extracts prepared from the control cell lines T24 (lanes 1 ± 3), MCF7 (lanes 9 ± 11) and BxPC-3 (lanes 13 ± 15). Repair reactions were performed in the presence of [ 32 P]dTTP and stopped after 15, 30 and 60 min. After only 15 min most of the repair synthesis supported by T24 and MCF7 cell extracts and occurring within the region of the AP site was associated with the 16-mer XbaI ± PstI fragment, demonstrating that close to Capan-1 extracts. 300 ng of pGEM X plasmids carrying a single AP site (lanes 1 ± 3, 5 ± 7, 9 ± 11 and 13 ± 15) or pGEM T control plasmids (lanes 4, 8, 12, 16) were incubated for 15, 30 and 60 min under standard repair conditions (see Materials and methods) with 30 mg protein of wild type T24 cell extract (lanes 1 ± 4), BRCA2 mutant Capan-1 cell extract (lanes 5 ± 8), wild type MCF7 extract (lanes 9 ± 12) and wild type BxPC-3 cell extract (lanes 13 ± 16). After the repair reaction, DNA was puri®ed and treated with XbaI ± PstI restriction endonucleases. The excised fragment(s) were resolved by denaturing PAGE and their length (7, 10, 13 and 16 nucleotides) determined by appropriate 32 P labelled oligonucleotide size markers. The relative amount of each fragment was determined by scanning densitometry and plotted as following: white, 7 mer; hatched, 10 mer; black, 13 mer 100% repair events were completed. A certain amount of unligated 7 mer fragments (20 ± 25% of total) persisted in reactions supported by BxPC-3 extracts, suggesting that this pancreatic adenocarcinoma cell line supports DNA ligation during BER of a single AP site at a lower rate than T24 or MCF7 cells. However, incomplete BER events persisted for longer time in reactions supported by BRCA2-mutant Capan-1 extract, as indicated by the persistence of 60 ± 80% unligated repair intermediates after 0 ± 30 min incubations (lanes 5 ± 6). In this experiment the unligated fragments were predominantly 7 nucleotides in length (50 ± 75%), suggesting that reduced ligation was associated with single nucleotide insertion BER pathway. However, signi®cant amounts of 10 ± 13 mer fragments were also observed (5 ± 13% of total repair synthesis) suggesting that PCNA-dependent BER involving multiple nucleotide incorporation was also aected. At later incubation times (60 min), almost all 7 mer fragments were rejoined while 12% of the 10 ± 13 mer fragments persisted. The total repair incorporation stimulated by the Capan-1 extract was similar to that stimulated by the wild type BxPC-3 T24 and MCF7 extracts, suggesting that the eciency of gap ®lling supported by BRCA2-mutant extracts was normal. Negligible repair synthesis was observed in control pGEM T plasmids incubated with the cell extracts (lanes 4, 8, 12, 16) , con®rming that repair synthesis was restricted to the AP site. Reactions containing Capan-1 extracts were characterized by extensive DNA fragmentation, detectable as a long smear of radiolabelled fragments (lanes 5 ± 7). As described below, this DNA fragmentation was substantially reduced by addition of exogenous DNA ligase activities, thus suggesting its linkage to the DNA ligation defect present in Capan-1.
A reduced rate of ligation during BER supported by Capan-1 extracts was also observed in reactions in which the substrate was a single U base (Figure 3 ). pGEM U plasmids were incubated with 30 mg protein of Capan-1 extracts (lanes 4 ± 7), MCF7 extracts (lanes 9 ± 12) and BxPC-3 extracts (lanes 14 ± 17) for 15, 30, 60 and 180 min. In this experiment, the percentage of incomplete events in BER supported by Capan-1 extracts was 67 ± 76% after 15 ± 30 min incubation (lanes 4, 5) after which time a progressive completion of BER patches could be observed, with 34 and 21% of fragments in which repair synthesis had occurred remaining unligated after 60 and 180 min, respectively (lanes 6, 7). No incomplete repair patches were observed in reactions supported by BRCA2 wild type MCF7 (lanes 9 ± 12) or BxPC-3 (lanes 14 ± 17) cell extracts, at any time point examined. With Capan-1 cell extracts (lanes 4 ± 7), 7 mers represented 17 and 48% of unligated fragments after 15 and 30 min incubations (lanes 4, 5), with remaining fragments being 10 and 13 bp long. After longer incubations (60 and 180 min ± lanes 6, 7), all of the single nucleotide insertion BER patches were ligated, though some incomplete PCNA-dependent BER events persisted as indicated by residual 10 and 13 bp products (34 and 21% of total repair incorporation in lanes 6 and 7, respectively). For comparison, the repair of a single AP site (pGEM X substrate) by Capan-1 extracts was also examined in this experiment (lanes 1 ± 3). Consistent with previous results (Figure 2) , 80, 65 and 44% of repair patches remained unligated after 15, 30 and 60 min incubations, respectively, with single nucleotide BER events (as measured by unligated 7 bp products) representing 53, 25 and 9% of incompleted repair patches, respectively. The total level of repair incorporation supported by Capan-1 extracts on pGEM U was 5.5-, 4.9-and 3.6-fold lower than that on pGEM X during 15, 30 and 60 min incubations, respectively (data not shown). This is in agreement with recent work showing that in vitro repair of U by human cell extracts is signi®cantly less ecient than repair of AP sites (Cappelli et al., 2000) .
Mean data from multiple experiments performed with pGEM X (upper panel) and pGEM U (lower panel) are shown in Figure 4 . As observed above (Figures 2 and 3) , the reduced rate of ligation of DNA repair patches in Capan-1 extracts was pronounced in Figure 3 DNA ligation defect in BER of a single U in Capan-1 extracts. 300 ng of pGEM U plasmids carrying a single U (lanes 4 ± 7, 9 ± 12, 14 ± 17) or pGEM T control plasmids (lanes 8, 13, 18) were incubated for 15, 30, 60 and 180 min under standard repair conditions (see Materials and methods) with 30 mg protein of BRCA2 mutant Capan-1 cell extract (lanes 4 ± 8), wild type MCF7 extract (lanes 9 ± 13) and wild type BxPC-3 cell extracts (lanes 14 ± 18). For comparison, Capan-1 extracts were also incubated with pGEM X plasmids containing a single AP site (lanes 1 ± 3). After the repair reaction, DNA was puri®ed and treated with XbaI ± PstI restriction endonucleases. The excised fragment(s) were resolved by denaturing PAGE. The relative amount of each fragment was determined by scanning densitometry and plotted as following: white, 7 mer; hatched, 10 mer; black, 13 mer comparison to T24 and MCF7 extracts with both pGEM X and pGEM U substrates. In comparison to BxPC-3, the ability of Capan-1 to rejoin repair patches was severely aected in the case of repair of a single U whilst a less evident defect was observed in the case of repair of a single AP site, with BxPC-3 extracts also displaying a relatively high level of unligated fragments in the latter case. The data also show that a signi®cant amount of 10 mer fragments, in addition to 7 mer fragments, can be observed when using Capan-1 extracts, thus indicating that the ligation defect in these cells involves both the single and multiple nucleotide insertion pathways.
In vitro complementation of reduced rates of ligation exhibited by Capan-1 cell extract
To determine whether the reduced rates of ligation during BER were linked to low levels of one or more DNA ligases, Capan-1 extracts were immunoblotted for quanti®cation of the levels of DNA ligase I, XRCC1/DNA ligase III, and DNA ligase IV ( Figure  5 ). DNA ligase III and DNA ligase I have been proposed as the major ligase activities involved in BER (Kubota et al., 1996; Prasad et al., 1996; Cappelli et al., 1997) and DNA ligase IV appears to participate in non homologous end joining (Grawunder et al., 1997; Teo and Jackson, 2000) . Levels of the three DNA ligases were similar or greater in Capan-1 mutant cell extracts (lane 4) than in MCF7 (lane 1), T24 (lane 2) and BxPC-3 (lane 3) control cell extracts. This was also true for XRCC1 protein, which interacts with and stabilizes DNA ligase III (Caldecott et al., 1994; 1995) . Given the apparent absence of reduced ligase levels in Capan-1 cells we next examined whether the elevated levels of unligated repair patches in BER reactions supported by Capan-1 extracts was due to reduced rates of ligation ( Figure 6 ). Puri®ed DNA ligase from bacteriophage T4 (1.5 units; lanes 3, 4) or human DNA ligase III protein (lanes 5, 6) was added to 15 (lanes 1, 3, 5) and 30 min (lanes 2, 4, 6, 7) BER reactions. The reduced rate of ligation in reactions supported by Capan-1 extracts (32 and 49% of BER products remaining incomplete after 15 or 30 min, respectively lanes 1, 2) was fully complemented by addition of either DNA ligase after only 15 min incubation. It was also noted that recombinant ligases counteracted the elevated nuclease activity in Capan-1 extracts, suggesting that this phenomenon also is related to the reduced rate of ligation. No incorporation was detected in pGEM T control plasmids, con®rming that the recombinant ligases were completing BER events located at the AP site (lane 7). 
Discussion
We report that Capan-1 cells that are mutated for the BRCA2 gene exhibit a reduced rate of DNA ligation during BER reactions in vitro. This reduced rate of ligation was observed during the repair of either a single AP site or a single U base and was complemented by the addition of recombinant DNA ligases. Capan-1 cell extracts also supported formation of large labelled fragments in both damaged and control substrates, as indicated by appearance during electrophoresis of extensive radiolabelled smears, which presumably resulted from nonspeci®c nicking and DNA polymerase activity within the vector backbone. Intriguingly, the appearance of these patches was also reduced by the addition of recombinant ligases ( Figure  6 , compare lanes 1 and 2 with lanes 3 ± 6). Thus, reduced ligation rates in Capan-1 extracts may not be restricted to one speci®c repair pathway but may represent a general ligation defect in these cells. The rate of ligation during BER was higher in three control cell lines including BxPC-3, a pancreatic adenocarcinoma cell line that is commonly employed as a control for Capan-1 cells (Abbott et al., 1998; Su et al., 1998; Yuan et al, 1999) . BxPC-3 and Capan-1 show a similar genetic status at a number of genes involved in control of cell proliferation including p53, p16 and Rb. However, unlike Capan-1 cells, BxPC-3 cells retain one wild type BRCA2 allele (Abbott et al., 1998) . The limited amounts of unligated repair patches that were observed in reactions supported by BxPC-3 extracts, particularly on pGEM X substrates (Figures 2 ± 4 ), may re¯ect a gene dosage eect, since this cell line does possess a single BRCA2 allele. Alternatively, it may re¯ect a general feature of pancreatic adenocarcinoma cell lines. Both Capan-1 cells and BRCA2-de®cient MEFs are defective in double-strand break repair and are sensitive to ionizing radiation and to drugs that induce double-strand breaks (Sharan et al., 1997; Abbott et al., 1998) . A role for BRCA2 in the repair of DNA breaks is suggested by several studies (reviewed in Welcsh et al., 2000) and the direct requirement of BRCA2 protein for the ionizing radiation-induced assembly of Rad51 complexes in vivo has been demonstrated (Yuan et al., 1999) . Given the size of the BRCA2 protein (3418 amino acids) it is possible that BRCA2 additionally interacts with DNA repair proteins other than Rad51 and is involved in more than one pathway. In this regard, Capan-1 cells are also hypersensitive to the alkylating agent MMS and this phenotype can be complemented by exogenous expression of wild type BRCA2 cDNA (Chen et al., 1998) . Although the cytotoxic damage induced by MMS is in part likely to be processed by homologous recombination, most MMS induced damage is repaired via BER. The reduced rate of DNA ligation during BER reactions supported by Capan-1 cell extracts could thus contribute to the sensitivity of Capan-1 cells to MMS.
The absence of full-length BRCA2 in Capan-1 cells results in slow growth rates and several weeks of cell culture were necessary to obtain a dozen million cells which was barely sucient to prepare extracts from (data not shown). That the low proliferation rate of Capan-1 is linked to the mutated status of BRCA2 can be inferred from the observation that (i) cultured ®broblasts from BRCA27/7 knockout mice are also characterized by low proliferation (Connor et al., 1997; Ludwig et al., 1997; Sharan et al., 1997; Suzuki et al., 1997) and (ii) BxPC-3 cells that have origin and dierentiation status similar to Capan-1 but retain a wild type BRCA2 allele display a normal proliferation Figure 6 Complementation of the ligation defect in Capan-1 extract by recombinant DNA ligases. 300 ng of pGEM X plasmids carrying a single AP site were incubated for 15 and 30 min under standard repair conditions with 30 mg protein of Capan-1 extract (lanes 1 ± 6). Reactions in lanes 3, 4 were performed in the presence of 1.5 units of DNA ligase from bacteriophage T4 and reactions in lanes 5, 6 were performed in the presence of 1 mg human DNA ligase III. DNA was then puri®ed and treated with XbaI ± PstI restriction endonucleases. As a control, 300 ng of undamaged pGEM T plasmids were incubated with 30 mg of Capan-1 cell extract under the same conditions (lane 7) rate (this study). The delayed cell cycle of BRCA2-de®cient cells might be mediated by overexpression of p53 and p21 (Connor et al., 1997) . It is possible that reduced ligase activity re¯ects reduced proliferation rate, since DNA ligase I levels are higher in proliferating cells. However, it should be noted that we failed to detect evidence for reduced levels of either DNA ligase I, XRCC1/DNA ligase III or DNA ligase IV in Capan-1. Nevertheless, that reduced BER eciency in reactions supported by Capan-1 extracts was due to reduced ligase activity was demonstrated by the ability of recombinant ligases to complement this eect. One or more DNA ligases in Capan-1 extracts is thus most likely less active than in wild type cells. It is interesting that Capan-1 cells are defective in RAD51 foci formation in response to radiation treatments, and that this defect is similarly unrelated to total levels of RAD51 (Yuan et al., 1999) . It is possible that BRCA2 also plays an important role in assembly of fully functional DNA ligation machinery, either directly (via protein interaction for example) or indirectly (perhaps through its eect on cell proliferation rates).
Materials and methods
Cell culture
The human pancreatic cancer cell lines Capan-1 and BxPC-3, the bladder cancer cell line T24 and the breast cancer cell line MCF7 were obtained from American Type Culture Collection and cultured as recommended.
Extracts
Protein extracts were prepared by the method of Tanaka et al. (1992) as described in Biade et al. (1998) . Brie¯y, 10 ± 50610 6 exponentially growing cells were harvested by trypsinization, washed three times with phosphate buered saline and resuspended in buer I (10 mM Tris-HCl, pH 7.8 and 200 mM KCl), at a concentration of 50610 6 cells/ml. After addition of an equal volume of buer II (10 mM TrisHCl, pH 7.8, 200 mM KCl, 2 mM EDTA, 40% glycerol, 0.2% Nonidet P-40, 2 mM dithiothreitol, 0.5 mM phenyl methyl sulfonyl¯uoride, 10 mg/ml aprotinin, 5 mg/ml leupeptin, 1 mg/ml pepstatin), the cell suspension was stirred for one hour at 48C and centrifuged at 16 000 g for 10 min. The supernatant was dispensed into aliquots and stored in liquid nitrogen.
In vitro BER assay
The procedures for preparation of plasmids carrying a single U (pGEM U) or a single AP site (pGEM X) at a de®ned location have been described (Frosina et al., 1996; (Figure 1) . Brie¯y, pGEM3Zf (+) single-stranded DNA was annealed with an oligonucleotide (22 bp) carrying a single U. Control pGEM T plasmids were prepared with an oligonucleotide carrying a thymine in the same position. Closed circular double-stranded DNA was obtained by incubating with T4 DNA polymerase, single-strand binding protein and T4 DNA ligase. The AP site was generated by incubation of pGEM U with E. coli uracil DNA glycosylase. The in vitro BER assay, described previously (Frosina et al., 1996; was employed. Brie¯y, 300 ng of the single lesion substrates pGEM X or pGEM U or the control substrate pGEM T were incubated with 30 mg of extract protein for the indicated times at 308C in the presence of [ 32 P]dTTP. After the repair reaction, the DNA reaction product was puri®ed, treated with the XbaI and PstI restriction endonucleases and separated by polyacrylamide gel electrophoresis in the presence of 7 M urea for 45 ± 60 min at 30 mA. The gel was subsequently dried and subject to autoradiography. The length of the fragments was determined by size markers represented by 5' end-labelled oligonucleotides of sequences identical to those of the expected excised fragments.
Immunodetection of DNA ligase III, XRCC1, DNA ligase IV and DNA ligase I Immunodetection of DNA ligase III, XRCC1, DNA ligase IV and DNA ligase I were conducted using as primary antibodies the anti-DNA ligase III polyclonal antibody TL-25, the anti-XRCC1 monoclonal antibody 33-2-5, an anti-DNA ligase IV polyclonal antibody (a gift from Dr Stephen P Jackson, Wellcome/CRC Institute, Cambridge, UK) and the anti DNA ligase I polyclonal antibody TL-6 (a gift from Dr Debbie Barnes, ICRF Clare Hall laboratories, South Mimms, UK), respectively.
Recombinant DNA ligases
T4 DNA ligase was purchased from Boehringer Mannheim. Recombinant human DNA ligase III was expressed as an Nterminal histidine-tagged polypeptide and puri®ed as described previously (Caldecott et al., 1996) .
